Working… Menu
Trial record 1 of 1 for:    intrommune
Previous Study | Return to List | Next Study

A Phase 1 Study of the Safety and Feasibility of Up-titration With INT301 in Adults With Sensitivity to Peanut.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04603300
Recruitment Status : Recruiting
First Posted : October 26, 2020
Last Update Posted : August 24, 2021
Information provided by (Responsible Party):
Intrommune Therapeutics

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : October 31, 2021
Estimated Study Completion Date : December 15, 2021